L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

NCT06788756 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
RECRUITING
Status
312
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Moleculin Biotech, Inc.